| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 7.9M | $343M | $43.35 | Nov 20, 2025 | Indirect |
| Mineralys Therapeutics, Inc. | Director, 10%+ Owner | Stock Option | 32.9K | Feb 13, 2025 | Indirect | ||
| Mineralys Therapeutics, Inc. | Director, 10%+ Owner | Stock Option | 0 | Feb 13, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | Nov 20, 2025 | 1 | -$43.4M | 4 | Nov 21, 2025 | Director, 10%+ Owner |
| MLYS | Mineralys Therapeutics, Inc. | Mar 13, 2025 | 1 | $3.5M | 4 | Apr 25, 2025 | Director, 10%+ Owner |
| MLYS | Mineralys Therapeutics, Inc. | Feb 13, 2025 | 3 | $0 | 4 | Feb 24, 2025 | Director, 10%+ Owner |
| MLYS | Mineralys Therapeutics, Inc. | Jul 24, 2024 | 1 | -$7.18M | 4 | Jul 26, 2024 | Director, 10%+ Owner |
| MLYS | Mineralys Therapeutics, Inc. | May 22, 2024 | 2 | $0 | 4 | Jan 7, 2025 | Director, 10%+ Owner |
| MLYS | Mineralys Therapeutics, Inc. | May 22, 2024 | 1 | $0 | 4 | May 23, 2024 | Director, 10%+ Owner |
| MLYS | Mineralys Therapeutics, Inc. | Jul 12, 2023 | 2 | $0 | 4 | Jul 14, 2023 | Director, 10%+ Owner |
| MLYS | Mineralys Therapeutics, Inc. | Feb 14, 2023 | 4 | $4M | 4 | Feb 16, 2023 | Director, 10%+ Owner |
| MLYS | Mineralys Therapeutics, Inc. | Feb 9, 2023 | 1 | $0 | 4 | Feb 13, 2023 | Director, 10%+ Owner |
| MLYS | Mineralys Therapeutics, Inc. | Feb 9, 2023 | 0 | $0 | 3 | Feb 9, 2023 | Director, 10%+ Owner |